TB

Tjeerd Barf

AB Acerta Pharma B.V.: 4 patents #1 of 18Top 6%
Merck: 1 patents #304 of 909Top 35%
Overall (2021): #26,741 of 548,734Top 5%
5
Patents 2021

Issued Patents 2021

Patent #TitleCo-InventorsDate
11166951 Therapeutic combinations of a BTK inhibitor, a PI3K inhibitor, a JAK-2 inhibitor, and/or a BCL-2 inhibitor Ahmed Hamdy, Wayne Rothbaum, Raquel Izumi, Brian Lannutti, Todd Covey +3 more 2021-11-09
11110088 Imidazopyrazine inhibitors of Bruton's tyrosine kinase Edwin de Zwart, Saskia Verkaik, Niels Hoogenboom, Dennis Demont 2021-09-07
11090302 Methods of treating chronic lymphocytic leukemia and small lymphocytic leukemia using a BTK inhibitor Ahmed Hamdy, Wayne Rothbaum, Raquel Izumi, Brian Lannutti, Todd Covey +3 more 2021-08-17
11059829 Crystal forms of (S)-4-(8-amino-3-(1-(but-2-ynoyl)pyrrolidin-2-yl)imidazo[1,5-a]pyrazin-1-yl)-N-(pyridin-2-yl)benzamide maleate Fritz Blatter, Tim Ingallinera, Edwin Aret, Cecile M. Krejsa, Jerry Evarts 2021-07-13
10934296 4-imidazopyridazin-1-yl-benzamides as Btk inhibitors Christiaan Gerardus Johannes Maria Jans, Adrianus Petrus Antonius De Man, Arthur A. Oubrie, Hans C. A. Raaijmakers, Johannes Bernardus Maria Rewinkel +2 more 2021-03-02